Stay updated on IGN002 Clinical Trial in Refractory NHL
Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.

Latest updates to the IGN002 Clinical Trial in Refractory NHL page
- ChecktodayChange DetectedAdded Revision: v3.4.2 to the page while removing the previous funding-status notice and Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check8 days agoChange DetectedA site-wide notice informs users about a lapse in government funding and the NIH Clinical Center's operating status, and the page revision has been updated to v3.4.1. There are no changes to the study details, eligibility criteria, or core page content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check15 days agoChange DetectedAdds a Show glossary toggle and updates page metadata. The labels 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' have capitalization changes, and the revision is bumped to v3.4.0.SummaryDifference0.3%

- Check29 days agoChange DetectedRevision: v3.3.4 is now displayed on the page, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check51 days agoChange DetectedA new Locations section appears with California as the study site. The label 'California Locations' was removed and the HHS Vulnerability Disclosure link is gone; the revision is updated to v3.3.3.SummaryDifference0.3%

- Check72 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.3.1 in the page footer; this is a minor metadata update with no impact on content or user experience. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL
Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.